Finance

Lists
PHR:NYSE
Phreesia Inc
$10.17
-1.64%
(-0.17) 1D
$10.17
0.00% (0.00)
After hours
Closed: Sep 10, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHR...
Open
$10.21
High
$10.39
Low
$10.10
Mkt. cap
631.26M
Avg. vol.
799.92K
Volume
0.00
P/E ratio
60.21
52-wk high
$25.68
52-wk low
$7.77
EPS
$0.17
Beta
0.86
Shares outstanding
62.07M
No. of employees
2K
Open
$10.21
High
$10.39
Low
$10.10
Mkt. cap
631.26M
Avg. vol.
799.92K
Volume
0.00
P/E ratio
60.21
52-wk high
$25.68
52-wk low
$7.77
EPS
$0.17
Beta
0.86
Shares outstanding
62.07M
No. of employees
2K
News stories
From web sources and news partners
Profile
Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake. Wikipedia
About Phreesia Inc
CEOChaim Indig
Employees1.79K
Founded2005
HeadquartersWilmington, Delaware, United States
SectorHealth care
Analyst ratings
Based on 12 analysts giving stock ratings to PHR in the past 3 months
Buy
Buy
6
Hold
6
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for PHR in the last 3 months.
Highest
Current $10.17
$19.00 (+86.82%)
Average
$13.30 (+30.78%)
Lowest
$10.00 (-1.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Daniels
William Blair
Buy
Maintained
-
-
09/08/2026
Parker Snure
Raymond James
Hold
Downgraded
$12.00
+18%
09/08/2026
Joseph Vruwink
Robert W. Baird
Hold
Maintained
$11.00
+8.2%
09/04/2026
Clark Wright
D.A. Davidson
Buy
Maintained
$13.00
+27.8%
09/04/2026
Jailendra Singh
Truist Financial
Hold
Maintained
-
-
09/03/2026
Ryan Halsted
RBC Capital
Buy
Maintained
$19.00
+86.8%
09/03/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$16.00
+57.3%
09/03/2026
Stan Berenshteyn
Wells Fargo
Hold
Reiterated
$10.00
-1.7%
09/03/2026
Ryan MacDonald
Needham
Buy
Reiterated
$14.00
+37.7%
09/03/2026
Glen Santangelo
Barclays
Hold
Maintained
$10.00
-1.7%
09/03/2026
Alexei Gogolev
J.P. Morgan
Hold
Reiterated
$14.00
+37.7%
06/25/2026
Sean Dodge
BMO Capital
Buy
Maintained
$14.00
+37.7%
06/22/2026
Jessica Tassan
Piper Sandler
Hold
Downgraded
$12.00
+18%
05/28/2026
Unknown Analyst
Jefferies
Buy
Maintained
$20.00
+96.7%
05/28/2026
Dan Waggoner
D.A. Davidson
Buy
Maintained
$14.00
+37.7%
05/28/2026
Daniel Grosslight
Citi
Hold
Reiterated
$12.00
+18%
05/28/2026
Unknown Analyst
KeyBanc
Buy
Reiterated
$12.00
+18%
04/13/2026
Scott Schoenhaus
KeyBanc
Buy
Reiterated
$12.00
+18%
04/13/2026
Aaron Kimson
Citizens JMP
Hold
Downgraded
-
-
04/01/2026
Jeffrey Garro
Stephens
Buy
Maintained
$20.00
+96.7%
03/31/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
$19.00
+86.8%
03/24/2026
Last report
Sep 2, 2026
Fiscal period
Q2 2027
EPS / Est. (USD)
$0.28 / $0.32
-14.34%miss
Revenue / Est. (USD)
129.46M / 128.99M
+0.36%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
120.33M
127.07M
130.94M
129.46M
Cost of goods sold
38.03M
40.39M
43.33M
43.18M
Cost of revenue
38.03M
40.39M
43.33M
43.18M
Research and development expenses
29.45M
30.92M
28.33M
27.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.66M
44.37M
42.57M
41.10M
Operating expense
76.59M
84.98M
80.85M
78.66M
Total operating expenses
114.62M
125.37M
124.19M
121.85M
Operating income
5.71M
1.69M
6.75M
7.61M
Other non operating income
1.01M
1.27M
-7.00K
-2.89M
EBT including unusual items
5.12M
-10.32M
4.72M
3.24M
EBT excluding unusual items
7.10M
-2.57M
4.74M
3.24M
Income tax expense
854.00K
-11.62M
1.76M
1.32M
Effective tax rate
16.66%
112.54%
37.26%
40.78%
Other operating expenses
-
-
-
-
Net income
4.27M
1.30M
2.96M
1.92M
Net profit margin
3.55%
1.02%
2.26%
1.48%
Earnings per share
0.31
0.44
0.27
0.28
Interest and investment income
700.00K
269.00K
297.00K
248.00K
Interest expense
-320.00K
-5.81M
-2.30M
-1.73M
Net interest expenses
380.00K
-5.54M
-2.00M
-1.48M
Depreciation and amortization charges
3.20M
3.51M
3.37M
3.34M
EBITDA
13.19M
7.67M
12.73M
13.58M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps